You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
啟明醫療(02500.HK)新一代經導管主動脈瓣置換系統完成全球首兩例臨床試驗
阿思達克 12-20 10:56
啟明醫療(02500.HK)公布,其自主研發的新一代經導管主動脈瓣置換(TAVR)系統Venus Vitae,於上周四(16日)成功進行全球首兩例應用於人體(First-in-Man,FIM)的臨床試驗,由阿根廷科達特斯Instituto De Cardiologia醫院的巴卡羅教授團隊主導完成。 主動脈瓣狹窄是最常見的心臟瓣膜病之一,容易導致冠狀動脈缺血、腦缺血等,從而引發心絞痛或者其他嚴重的併發症,目前已經成為全球因瓣膜病導致死亡的主要病因。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account